Balsari A, Cerofolini M, Ghione M
Department of Biomedical Sciences and Biotechnologies, University of Brescia, Italy.
Int J Immunopharmacol. 1991;13(2-3):155-8. doi: 10.1016/0192-0561(91)90093-m.
Injection into mice of the anthracycline cytotoxic derivative Doxorubicin (DXR) covalently bound to bovine serum albumin (BSA) was associated with antigen-specific depression of the primary (but not of the secondary) antibody reaction to the carrier, whereas DXR and BSA injected in the form of a mixture caused no such effect. Tetanus toxoid completely prevented the carrier-specific inhibiting effect when administered at the same time as, but not three days before or after, injection of the DXR-BSA conjugate. Possible mechanisms of the antigen-specific immunodepression and its prevention by unrelated antigen are discussed.
将与牛血清白蛋白(BSA)共价结合的蒽环类细胞毒性衍生物阿霉素(DXR)注射到小鼠体内,会导致对载体的初次(而非二次)抗体反应出现抗原特异性抑制,而以混合物形式注射的DXR和BSA则不会产生这种效果。当与DXR-BSA偶联物同时注射(而非在其注射前或后三天)时,破伤风类毒素可完全预防载体特异性抑制作用。本文讨论了抗原特异性免疫抑制及其被无关抗原预防的可能机制。